US FDA Still Not Scheduling In-Person Meetings Despite Sponsor Requests

 
• By Derrick Gingery
  
FDA not having in-person meetings
Some stakeholders are growing inpatient for the FDA to resume in-person meetings. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from US FDA Performance Tracker

More from Regulatory Trackers